Inventor · disambiguated record
Gang Yin
Also filed as: YIN GANG
24 granted patents·18 pending applications·125 citations·filing 2006–2025
95Inventor score
Top patents by PatentIndex Score
42 records- 0194US10596270B2Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugatesSUTRO BIOPHARMA INC·Filed 2018·Granted Mar 24, 2020·15 cites·24 claims
- 0294US9764039B2Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2014·Granted Sep 19, 2017·20 cites·36 claims
- 0393US9424670B1Interactive threshold setting for pie chartsIBM·Filed 2016·Granted Aug 23, 2016·17 cites·1 claims
- 0492US11744876B2Immunomodulator antibody drug conjugates and uses thereofSUTRO BIOPHARMA INC·Filed 2020·Granted Sep 5, 2023·4 cites·47 claims
- 0592US10669347B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·5 cites·16 claims
- 0692US9738724B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2013·Granted Aug 22, 2017·12 cites·35 claims
- 0791US9732161B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2013·Granted Aug 15, 2017·7 cites·20 claims
- 0890US8778631B2Mono charging system for selectively introducing non-native amino acids into proteins using an in vitro protein synthesis systemVOLOSHIN ALEXEI M·Filed 2010·Granted Jul 15, 2014·32 cites·31 claims
- 0988US10501558B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted Dec 10, 2019·3 cites·20 claims
- 1083US11958909B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2020·Granted Apr 16, 2024·1 cites·20 claims
- 1183US2025002604A1Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1282US2025090676A1Anti-folate receptor alpha antibody conjugates and their usesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1381US11098107B2Antibodies with engineered CH2 domains, compositions thereof and methods of using the sameSUTRO BIOPHARMA INC·Filed 2017·Granted Aug 24, 2021·2 cites·25 claims
- 1481US2025346650A1Antibodies with engineered ch2 domains, compositions thereof and methods of using the sameSUTRO BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 1580US9569082B1Interactive threshold setting for pie chartsIBM·Filed 2016·Granted Feb 14, 2017·3 cites·1 claims
- 1679US10487133B2Codon optimization for titer and fidelity improvementSUTRO BIOPHARMA INC·Filed 2015·Granted Nov 26, 2019·2 cites·26 claims
- 1777US12144869B2Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2023·Granted Nov 19, 2024·0 cites·24 claims
- 1877US2024010715A1Antibodies with engineered ch2 domains, compositions thereof and methods of using the sameSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1977US2025135025A1Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugatesSTURO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2077US2025018054A1Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2175US12226490B2Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary classSUTRO BIOPHARMA INC·Filed 2023·Granted Feb 18, 2025·0 cites·38 claims
- 2274US2025304723A1Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 2372US12427201B2Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugatesSUTRO BIOPHARMA INC·Filed 2019·Granted Sep 30, 2025·0 cites·27 claims
- 2472US12398197B2Antibodies with engineered CH2 domains, compositions thereof and methods of using the sameSUTRO BIOPHARMA INC·Filed 2021·Granted Aug 26, 2025·0 cites·16 claims
- 2572US12252552B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2019·Granted Mar 18, 2025·0 cites·32 claims
- 2672US2023114070A1Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2771US2024101631A1Human interleukin-2 conjugates biased for the interleukin-2 receptor beta-gammac dimer and conjugated to a nonpeptidic, water-soluble polymerMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2869US2024139285A1Immunomodulator antibody drug conjugates and uses thereofSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2968US12071477B2Anti-folate receptor alpha antibody conjugated with hemiasterlinsSUTRO BIOPHARMA INC·Filed 2018·Granted Aug 27, 2024·0 cites·26 claims
- 3065US11827684B2Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc dimer and conjugated to a nonpeptidic, water-soluble polymerMERCK SHARP & DOHME LLC·Filed 2021·Granted Nov 28, 2023·0 cites·54 claims
- 3165US10048849B2Interactive threshold setting for pie chartsIBM·Filed 2016·Granted Aug 14, 2018·1 cites·16 claims
- 3263US2024124585A1Anti-cd3 antibodies, compositions comprising anti-cd3 antibodies and methods of making and using anti-cd3 antibodiesSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3362US11344626B2Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted May 31, 2022·0 cites·39 claims
- 3458US2022089690A1Method for large scale production of antibodies using a cell-free protein synthesis systemSUTRO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3556US2025248240A1Display panel, manufacturing method therefor, and display apparatusBOE TECHNOLOGY GROUP CO LTD·Filed 2023·Application pending·0 cites
- 3652US2023095053A1Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3752US2024238070A1Novel self-ligating orthodontic bracketHANGZHOU PENGWU MEDICAL EQUIPMENT CO LTD·Filed 2021·Application pending·0 cites
- 3847US2007122693A1Battery cover mechanismFIH CO LTD·Filed 2006·Application pending·0 cites
- 3947US2007101541A1Hinge assembly for portable electronic devicesSUTECH TRADING LTD·Filed 2006·Application pending·0 cites
- 4045US2010184134A1Dual charging system for selectively introducing non-native amino acids into proteins using an in vitro synthesis methodSUTRO BIOPHARMA INC·Filed 2010·Application pending·0 cites
- 4143US11755225B2Systems and methods for data storageSHANGHAI UNITED IMAGING HEALTHCARE CO LTD·Filed 2020·Granted Sep 12, 2023·0 cites·18 claims
- 4242USD1024421SMachine for manufacturing cigaretteYIN GANG·Filed 2022·Granted Apr 23, 2024·1 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Gang Yin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →